BBa_K1647019

BBa_K1647019 Version 1

Component

Source:
http://parts.igem.org/Part:BBa_K1647019
Generated By: https://synbiohub.org/public/igem/igem2sbol/1
Created by: Yun Xue
Date created: 2015-09-14 11:00:00
Date modified: 2015-09-18 10:55:39

Cap-AAP2, a improved antimicrobial peptide which can kill the S.mutans selectively and have changeab



Types
DnaRegion

Roles
Composite

engineered_region

Sequences BBa_K1647019_sequence (Version 1)

Description

The CAP is a short peptide derived from the competence stimulation peptide(CSP) which can binding to the receptors on the membrane of the S.mutans selectively. APP2 , a antimicrobial peptide, can achieve high activity exclusively at low environmental pH to target bacterial species like Streptococcus mutans that produce acid and thrive under the low pH conditions detrimental for tooth integrity. However, at pH 7.5, it has no effect on cell viability. The part is a new improved peptide ,based on the fusion of a S.mutans-specific targeting peptide domain with a special antimicrobial peptide domain which has strong antibacterial ability at acid environment ,however , weakly at neural pH ,which can restrain and even kill the S.mutans specifically as well as have weak effect on other bacteria at neural and base pH.

Notes

To reduce the effect of the CAP on the Bac8c, the CAP only has the least effective sequence of the CSP. Besides, we design an intersequence ,GGG, put between the CAP and Bac8c for the same goal.

Source

None for the moment

igem#experience
None
 
igem#status
Planning
 
synbiohub#ownedBy
user/james
 
synbiohub#ownedBy
user/myers
 
synbiohub#topLevel
BBa_K1647019/1